BRIEF-Janssen Biotech says FDA approves STELARA (ustekinumab)
September 26, 2016 at 09:26 AM EDT
* Janssen Biotech says FDA approves STELARA (ustekinumab) for treatment of adults with moderately to severely active crohn's disease Source text for Eikon: Further company coverage:
